As a researcher you want to reach out to as many people as possible. The Danish Society for Pharmacoepidemiology wishes to assist in this. Therefore, we have started this concept with video presentations. If you have a research project or an article you want to present, feel free to contact us
For more information of how to record the presentation (and a presentation guideline), please follow this link.
| Date | Presenter | Paper | Theoretical topic | Link to previous presentations |
|---|---|---|---|---|
| Dec 5 2019 | Anton Pottegård & Sebastian Schneeweiss | Recording: Due to technical problems, parts of the discussion are missing | Inauguration seminar | Recording |
| Nov 6 2019 | Shirley Wang & Anton Pottegård | https://www.repeatinitiative.org/ | Design visualization, unambiguous reporting and replicability of real-world evidence | Recording |
| Jun 27 2019 | Thomas Ahern | Phthalate Exposure and Breast Cancer Incidence: A Danish Nationwide Cohort Study | Old school inferential paradigms - why reviewers are not always right | Recording |
| May 2019 | Anton Pottegård | Dr. Med.Sci dissertation defence | Pharmacoepidemiological assessment of drug-cancer associations | Recording |
| May 1 2019 | Kasper Adelborg | Use of histamine H2 receptor antagonists and outcomes in patients with heart failure: a nationwide population-based cohort study | New-user active comparator cohort studies | Recording |
| Mar 2019 | Henrik Støvring | Dr. Med.Sci dissertation defence | Using prescription data as indicators of disease or drug use, new analytic methods based on renewal processes | Recording |
| Mar 27 2019 | Morten Schmidt | Diclofenac use and cardiovascular risks: series of nationwide cohort studies | Diclofenac and cardiovascular risks | Recording |
| Feb 28 | Marie Hargreave | Maternal use of fertility drugs and risk of cancer in children—A nationwide population‐based cohort study in Denmark | Seperating effects of the treatment from the underlying disease | Recording |
| Jan 30 2019 | Ellen Løkkegaard | Using prescription registries to define continuous drug use: how to fill gaps between prescriptions. Conditioning on future exposure to define study cohorts can induce bias: the case of low-dose acetylsalicylic acid and risk of major bleeding. | Conditioning on the future in pharmacoepidemiology | Recording |
| Oct 26 2018 | Anton Pottegård | Use of antipsychotics and risk of breast cancer: a Danish nationwide case-control study. | Exposure ascertainment in cancer studies | Recording |
| Sep 28 2018 | Lina Steinrud Mørch | Association of Hormonal Contraception With Suicide Attempts and Suicides | Surveillance and healthy user bias | Recording |
| May 2016 | Lotte Rasmussen | Validity of the Prescriber Information in the Danish National Prescription Registry | validity of the prescriber information recorded in the Danish National Prescription Registry | Recording |
| April 2016 | Michael Busch-Sørensen | ‘Real World Data’, Usual practice, confounding og randomization is a current discussed mixture | Recording | |
| Feb 2016 | Jennifer Lund & Bradley Layton | Propensity score methods for confounding control in nonexperimental research | Propensity score methods: An introduction to Concepts and analysis | Recording |
| Jan 2016 | Daniel Pilsgaard Henriksen | Comparison of the Five Danish Regions Regarding Demographic Characteristics, Healthcare Utilization, and Medication Use--A Descriptive Cross-Sectional Study. | Recording | |
| May 2015 | Jesper Hallas & Henrik Toft Sørensen | Danish pharmacoepidemiology the past 25 years | Recording | |